Claro Advisors LLC Trims Stake in The Clorox Company (NYSE:CLX)

Claro Advisors LLC lessened its stake in The Clorox Company (NYSE:CLXFree Report) by 19.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,321 shares of the company’s stock after selling 1,278 shares during the period. Claro Advisors LLC’s holdings in Clorox were worth $864,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. Prospera Private Wealth LLC acquired a new position in Clorox in the 3rd quarter valued at about $27,000. Continuum Advisory LLC increased its position in Clorox by 300.0% in the 3rd quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock valued at $30,000 after acquiring an additional 138 shares during the period. Quarry LP increased its position in Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the period. Carolina Wealth Advisors LLC acquired a new position in Clorox in the 3rd quarter valued at about $48,000. Finally, Friedenthal Financial acquired a new position in Clorox in the 3rd quarter valued at about $49,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the topic of several recent research reports. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and boosted their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays boosted their target price on Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. boosted their target price on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Evercore ISI dropped their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. Four investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $157.46.

View Our Latest Report on Clorox

Clorox Price Performance

CLX stock opened at $157.32 on Tuesday. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock’s 50 day moving average price is $164.55 and its 200 day moving average price is $156.00. The firm has a market cap of $19.47 billion, a P/E ratio of 54.82, a PEG ratio of 3.04 and a beta of 0.42.

Clorox (NYSE:CLXGet Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the company earned $0.49 EPS. Clorox’s revenue was up 27.0% on a year-over-year basis. On average, sell-side analysts expect that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.10%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio is presently 170.03%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.